logo

For the Inventor, By the Inventor

Berlin, Germany

Robert C Nickolson

This inventor holds 9 USPTO granted patents. Top assignees: Schering Aktiengesellschaft, Other. Active years: 1977-1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert C Nickolson. Retrieved from https://idiyas.com/inventor/robert-c-nickolson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9

% Patents Active = 100.0

Average Co-Inventor Count = 3.2

ph-index = 2

Forward Citations = 14(Granted Patents)


Company Filing History:

goldMedal8 out of 1,409 
 
Schering Aktiengesellschaft
 patents
silverMedal1 out of 834,453 
Other
 patents

Years Active: 1977-1993

Loading Chart...
9 patents (USPTO):Explore Patents
1. 5190973 - 20-alkyl-7-oxoprostacyclin derivatives useful as pharmaceuticals (1993-03-02),
2. 4721729 - Novel carbacyclins, process for the preparation thereof, and their use (1988-01-26),
3. 4532236 - Certain prostacyclins and their blood-pressure-lowering and (1985-07-30),
4. 4472310 - 5.beta.-Hydroxy-.DELTA..sup.6 -steroids and process for the preparation (1984-09-18),
5. 4348327 - Process for the preparation of 17.alpha.-hydroxy- and (1982-09-07),
6. 4089852 - Process for the preparation of 21-hydroxy-16-pregnen-20-one derivatives (1978-05-16),
7. 4033995 - D-homo steroids (1977-07-05),
8. 4029692 - Steroid carboxylic acids and derivatives (1977-06-14),
9. 4025563 - Novel D-homo steroids (1977-05-24),

Title: The Innovations of Robert C. Nickolson

Introduction

Robert C. Nickolson is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceuticals, holding a total of 9 patents. His work focuses on innovative compounds that have potential therapeutic applications.

Latest Patents

Among his latest patents, one includes the invention of 20-alkyl-7-oxoprostacyclin derivatives useful as pharmaceuticals. This invention concerns 20-alkyl-7-oxoprostacyclin derivatives of general Formula I, wherein R₁ is the residue OR₃, where R₃ means hydrogen or alkyl of 1-10 carbon atoms, optionally substituted by halogen, phenyl, C₁-C₄-alkoxy, or C₁-C₄-dialkylamino. Additionally, he has developed novel carbacyclins, which are described by Formula I, wherein R₁ is an alkyl, cycloalkyl, aryl, aralkyl, or heterocyclic group.

Career Highlights

Throughout his career, Robert has worked with prominent companies, including Schering Aktiengesellschaft. His innovative work has led to advancements in pharmaceutical chemistry and has contributed to the development of new therapeutic agents.

Collaborations

Robert has collaborated with notable colleagues such as Rudolf Wiechert and Ulrich Kerb, enhancing the scope and impact of his research.

Conclusion

Robert C. Nickolson's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of new medical therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…